NEUMORA THERAPEUTICS INC (NMRA) Stock Income Statement
NASDAQ:NMRA - US6409791000 - Common Stock
1.73 USD
-0.03 (-1.7%)
1.73 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 264.54M | 263.46M | 188.19M | 122.87M | 80.32M | |||
| Research and Development | 197.42M | 200.93M | 142.72M | 91.75M | 55.78M | |||
| Selling, General, and Administrative Expenses | 67.13M | 62.54M | 45.48M | 31.12M | 24.55M | |||
| Operating Income | -264.54M | -263.46M | -188.19M | -122.87M | -80.32M | |||
| Interest Income/Expense | 13.19M | 19.93M | 16.61M | 4.56M | 0.00 | |||
| Other Income/Expense | -547.00K | -78.00K | -170.00K | 410.00K | 10.00K | |||
| Non Recurring Items | N/A | N/A | -63.90M | -13.00M | -157.00M | |||
| Income Before Taxes | -251.91M | -243.61M | -235.66M | -130.90M | -237.31M | |||
| Income Tax | 183.00K | 178.00K | 268.00K | N/A | N/A | |||
| Net Income | -252.09M | -243.79M | -235.93M | -130.90M | -237.31M | |||
| EBITDA | -264.06M | -262.83M | -187.53M | -122.28M | -79.78M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.57 | -1.53 | -1.49 | -0.86 | -1.56 | |||
| Non GAAP EPS | -1.57 | -1.53 | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD